ProShares Ultra NASDAQ Biotechnology
33 hedge funds and large institutions have $21.7M invested in ProShares Ultra NASDAQ Biotechnology in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 5 closing their positions.
Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
8
Reduced
12
Closed
5
Calls
$10.4M
Puts
$24.6M
Net Calls
-$14.1M
Net Calls Change
-$12.4M